Adam Acosta

White & Case (Washington)
Lawyer (Associate)

Adam Acosta is an associate in the Firm’s Global Antitrust and Competition Practice. His practice focuses on antitrust litigation, government investigations, and related counseling. Mr. Acosta represents clients in a wide range of industries and frequently represents clients in the pharmaceutical industry with cases involving allegations of reverse payment settlements and product hopping. Prior to joining White & Case, Mr. Acosta completed a two-year clerkship in the US District Court for the Southern District of Indiana. He currently serves as an elected board member for the Hispanic Bar Association of DC and is active in the American Bar Association’s Antitrust Section.

Distinctions

Linked author

White & Case (Washington)

Articles

30 Bulletin

Adam Acosta, Eric Grannon The US FTC and the FDA issue a joint statement and plan seeking to advance biosimilar competition and combat deceptive and anticompetitive practices in the biologic marketplace

30

On February 3, 2020, the Federal Trade Commission ("FTC") and the Food and Drug Administration ("FDA") issued a joint statement and plan seeking to advance biosimilar competition and combat deceptive and anticompetitive practices in the "biologic marketplace." As discussed below, the FTC and (...)

Send a message